Filter
1176
Text search:
drug-resistant
TB
Featured
120
327
Language
Document type
805
121
106
37
36
30
22
13
2
2
1
1
Countries / Regions
58
52
42
39
38
21
21
19
19
19
19
18
18
17
15
15
15
13
13
13
13
13
13
13
12
11
11
9
7
6
6
6
6
6
5
5
5
5
5
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
457
110
34
14
11
11
10
Toolboxes
549
118
85
20
17
15
14
12
12
11
11
11
6
4
3
3
3
2
2
2
2
Accessed November 2017
12 countries have a high TB estimated burden with an incidence rate more than 45 per 100 000 population They represent 88 of the cases in the Region
In 2019 the TB case detection gap in the Region
...
Примеры надлежащей практики в области укрепления систем здравоохранения с целью профилактики и лечения туберкулеза и лекарственно-устойчивого туберкулеза
This document provides practical guidance on planning and implementing next-generation sequencing (NGS) technology for characterization of Mycobacterium tuberculosis complex (MTBC) bacteria. The aim is to detect mutations associated with drug resistance in the context of a surveillance system for tu
...
Preventing tuberculosis infection from progressing to tuberculosis disease is a crucial component of the goal to eliminate tuberculosis. When deciding on the use of tuberculosis preventive therapy among household contacts, policy makers regularly ask questions, such as whether tuberculosis preventiv
...
The END TB Strategy
Интеграция совместного оказания услуг в связи с ТБ и ВИЧ во всеобъемлющий пакет помощи для потребителей инъекционных нарко
...
This training toolkit by the European Laboratory Initiative for TB, HIV and Viral Hepatitis provides a unique combination of practical guidance and expert advice on the interpretation of selected WHO-endorsed tests for
...
Tuberculosis MDR-TB & XDR-TB The 2008 Report
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
ПАКЕТ МЕР ПО РЕАЛИЗАЦИИ ПОЛИТИКИ В ОТНОШЕНИИ ВНЕДРЕНИЯ НОВЫХ ПРОТИВОТУБЕРКУЛЕЗНЫХ ПРЕПАРАТОВ
Of the more than 10 million people estimated to have fallen ill with tuberculosis (TB) in 2022, just over 400 000 people developed TB resistant to rifampicin (RIF), and 1.3 million people developed
...
Tuberculosis (TB) and particularly drug-resistant TB continue to represent major public health threats in the WHO European Region. This docum
...
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious di
...
